CellaVision AB (LTS:0MR5)
kr 273.5 0 (0%) Market Cap: 6.34 Bil Enterprise Value: 6.32 Bil PE Ratio: 44.65 PB Ratio: 8.76 GF Score: 98/100

Q4 2022 CellaVision AB Earnings Call Transcript

Feb 07, 2023 / 10:00AM GMT
Release Date Price: kr212.25 (-17.01%)
Operator

Welcome to CellaVision Q4 Report 2022. (Operator Instructions) Now I will hand the conference over to CEO, Simon Ostergaard. Please go ahead.

Simon Ostergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much for the introduction, and welcome, everybody to the conference call for CellaVision, where we report our Q4 results. So as said, I will give a fourth quarter highlights, and then we can take questions.

So our headline this time around is that we have an underlying demand for our services and offerings that we deem unchanged, but we certainly have external challenges that are interesting, which means that we are considering our quarter as another soft quarter on the top line; however, with control on our business and our cost base.

We ended the fourth quarter with SEK 152 million in revenue. That represents a negative growth of minus 7% or with currency effect of plus 10%, then we actually had an organic decrease of 17%.

Okay. Of course, we're up against tough compares

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot